Published in N Engl J Med on July 04, 2013
Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64
Patent foramen ovale and cryptogenic stroke. N Engl J Med (2013) 1.18
Patent foramen ovale and cryptogenic stroke. N Engl J Med (2013) 1.17
Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke (2009) 4.14
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol (2008) 2.77
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA (2011) 2.27
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol (2006) 2.27
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol (2010) 1.93
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke (2006) 1.86
Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord (2004) 1.85
Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials. Stroke (2013) 1.81
Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke (2011) 1.74
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66
Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64
Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet (2010) 1.62
Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med (2015) 1.61
Reporting clinical trial results to inform providers, payers, and consumers. Health Aff (Millwood) (2005) 1.57
Personalised medicine: not just in our genes. BMJ (2012) 1.51
Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke (2006) 1.47
Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ (2010) 1.43
Much cheaper, almost as good: decrementally cost-effective medical innovation. Ann Intern Med (2009) 1.40
Evidence-based medicine and the hard problem of multimorbidity. J Gen Intern Med (2014) 1.34
Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med (2013) 1.33
The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28
Stroke--an equal opportunity for the initiation of statin therapy. N Engl J Med (2006) 1.22
A CTSA agenda to advance methods for comparative effectiveness research. Clin Transl Sci (2011) 1.21
Multimorbidity and evidence generation. J Gen Intern Med (2014) 1.17
Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci (2011) 1.14
ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke (2010) 1.13
The empirical basis for determinations of medical futility. J Gen Intern Med (2010) 1.13
Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg (2003) 1.08
Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials. Circ Cardiovasc Qual Outcomes (2014) 1.07
American Academy of Neurology replies to Jeanne Lenzer. BMJ (2013) 1.07
Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis (2013) 1.06
Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm (2008) 1.05
Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci (2003) 1.05
Benchmarks and determinants of adherence to stroke performance measures. Stroke (2008) 1.04
Obstructive hydrocephalus from venous sinus thrombosis. Neurocrit Care (2009) 1.01
Patent foramen ovale and cryptogenic stroke. N Engl J Med (2008) 1.00
6 EZ steps to improving your performance: (or how to make P4P pay 4U!). JAMA (2008) 0.98
A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol (2007) 0.97
How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc (2012) 0.97
Are unadjusted analyses of clinical trials inappropriately biased toward the null? Stroke (2009) 0.95
Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J (2011) 0.95
Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet Med (2010) 0.94
Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. Am J Kidney Dis (2013) 0.94
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement (2012) 0.94
The Surgical Apgar Score in hip and knee arthroplasty. Clin Orthop Relat Res (2010) 0.94
Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Front Neurol (2012) 0.91
Aggregating and disaggregating patients in clinical trials and their subgroup analyses. Ann Intern Med (2010) 0.90
Controversies in cardioembolic stroke. Curr Treat Options Cardiovasc Med (2015) 0.90
25-hydroxyvitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity? Rheumatol Int (2011) 0.85
Seizures do not increase in-hospital mortality after intracerebral hemorrhage in the nationwide inpatient sample. Neurocrit Care (2013) 0.84
Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke (2013) 0.84
Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database. J Thorac Oncol (2013) 0.84
Rethinking trial strategies for stroke and patent foramen ovale. Curr Opin Neurol (2010) 0.84
Stroke prevention--insights from incoherence. N Engl J Med (2008) 0.82
The potential of training to increase acceptance and use of computerized decision support systems for medical diagnosis. Hum Factors (2006) 0.82
Gender differences in tPA-related arterial recanalization. Stroke (2005) 0.82
The Stroke Practice Improvement Network: a quasiexperimental trial of a multifaceted intervention to improve quality. J Stroke Cerebrovasc Dis (2010) 0.82
Cervicocranial arterial dissection. Curr Treat Options Neurol (2007) 0.80
Intracranial vertebrobasilar artery dissection associated with postpartum angiopathy. Stroke Res Treat (2009) 0.80
The treatment of spinal cord ischemia following thoracic endovascular aortic repair. Neurocrit Care (2007) 0.79
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care (2015) 0.79
Detecting mood disorder in resource-limited primary care settings: comparison of a self-administered screening tool to general practitioner assessment. J Med Screen (2013) 0.78
Stroke associated with Barth syndrome. J Child Neurol (2006) 0.78
Primary angioplasty or thrombolysis for acute myocardial infarction? Lancet (2003) 0.78
The Lake Wobegon Effect: Why Most Patients Are at Below-Average Risk. Ann Intern Med (2015) 0.78
Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference. Circ Cardiovasc Qual Outcomes (2011) 0.77
The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study. Cerebrovasc Dis (2015) 0.77
Antiplatelet strategies for secondary prevention of stroke and TIA. Curr Atheroscler Rep (2014) 0.77
Accounting for center effects in multicenter trials. Epidemiology (2010) 0.77
Improved perioperative outcomes from carotid endarterectomy: yet another statin side effect? Stroke (2005) 0.77
Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction. Circ Heart Fail (2011) 0.77
Predictors of outcome in patients with spinal cord ischemia after open aortic repair. Neurocrit Care (2013) 0.77
Pure sensory stroke from cortical infarction. Neurology (2002) 0.75
Recognition of Stroke by EMS is Associated with Improvement in Emergency Department Quality Measures. Prehosp Emerg Care (2016) 0.75
Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH). BJU Int (2014) 0.75
Teaching NeuroImages: occlusion of all 4 major extracranial vessels. Neurology (2010) 0.75
Prognostic models for older adults. JAMA (2012) 0.75
Towards an epidemiology of the known unknowns in cryptogenic stroke. Heart (2012) 0.75
Endocarditis is a common stroke mechanism in hemodialysis patients. Stroke (2014) 0.75
Toward a better understanding of PFO and stroke risk. Neurology (2013) 0.75
Author response. Neurology (2014) 0.75
Pharmacologic interventions for knee osteoarthritis. Ann Intern Med (2015) 0.75
Serum creatinine does not improve early classification of ischemic stroke caused by small artery occlusion. J Stroke Cerebrovasc Dis (2007) 0.75
History of transient ischaemic attack, myocardial infarction and hyperlipidaemia affects outcome following carotid artery stenting. EuroIntervention (2015) 0.75
Differences in triage thresholds for patients presenting with possible acute coronary syndromes: more than meets the eye. J Investig Med (2006) 0.75
Differences in response to reperfusion therapies in acute stroke between men and women: mediated by sex or by chance? Stroke (2006) 0.75
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol (2017) 0.75
Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality. Value Health (2006) 0.75